EHRA Premium Access

Characteristics of an arrhythmogenic substrate and results of catheter ablation of ventricular arrhythmias in patients with desmoplakin mutation associated arrhythmogenic cardiomyopathy


About the speaker

Associate Professor Petr Peichl

IKEM, Prague (Czechia)
8 presentations
0 follower

8 more presentations in this session

Zero-fluoroscopy catheter ablation for treatment of atrial fibrillation

Speaker: Mr M. Jan (Ljubljana, SI)


Long-term outcomes of catheter ablation of monomorphic ventricular tachycardia in repaired tetralogy of Fallot

Speaker: Doctor M. Laredo (Paris, FR)


Targeting the hidden substrate unmasked by right ventricular extrastimulation improves ventricular tachycardia ablation outcome after myocardial infarction

Speaker: Doctor M. De Riva Silva (Leiden, NL)


Comparison of procedural endpoints for ablation of post-myocardial infarction ventricular tachycardia

Speaker: Doctor M. Wolf (Antwerp, BE)


Electroanatomical voltage mapping validated by full human heart histology in non-ischemic cardiomyopathy

Speaker: Ms C. Glashan (Leiden, NL)


Access the full session

Rapid Fire session 6 - Mechanisms and strategies for catheter ablation

Speakers: Associate Professor P. Peichl, Mr M. Jan, Doctor M. Laredo, Doctor M. De Riva Silva, Doctor M. Wolf...

About the event



18 June - 21 June 2017

Sessions Presentations

Related content

Open Access

CRT, conduction system and alternative site pacing.

29 August 2021

Open Access

How the new guidance will impact the treatment of elderly atrial fibrillation patients in clinical practice.

28 August 2021

Open Access

What is new in the 2021 EHRA Practical Guide on the use of NOACs in patients with atrial fibrillation.

28 August 2021

This platform is supported by

logo Novo Nordisk